Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
See Latest ArticlesPharmacotherapy in pediatric obesity: Current agents and future directions
Reviews in Endocrine and Metabolic Disease, 08/20/09
Uli NK et al. – Childhood obesity is emerging as a major public health threat, with adverse implications on the health of individuals and long–term costs to society. Family–based lifestyle interventions with behavioral modification, diet and exercise form the mainstay of treatment. Lack of coverage of medications by insurance and high out–of–pocket costs may be limiting factors to some families. Adverse effects necessitate careful monitoring and may lead to discontinuation of medication. Pharmacologic agents with novel mechanisms of action offer hope of improved efficacy, tolerability and safety.
Today in Pediatric Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Pilot Trial of Pramlintide Home Usage in Adolescents With Type 1 Diabetes
Pediatrics, 11/09/09
Radioactive iodine for hyperthyroidism in children and adolescents: referral rate and response to treatment
Clinical Endocrinology, 11/18/09
Paediatric diabetic ketoacidosis
Continuing Education in Anaesthesia, Critical Care & Pain , 11/18/09
Sponsor
Article Search
Sponsor
Sponsor